Results 61 to 70 of about 27,055 (203)

Sulfonylurea herbicides

, 1991
Available from British Library Document Supply Centre- DSC:q91/15871(Sulfonylurea) / BLDSC - British Library Document Supply CentreSIGLEGBUnited ...
Smith, C, PJB Publications Ltd., Richmond (United Kingdom)   +1 more
core  

Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor I. Binding characteristics [PDF]

, 1994
Glimepiride is a novel sulfonylurea drug for treatment of non-insulin-dependent diabetes mellitus with higher blood sugar lowering efficacy in diabetic patients than glibenclamide raising the question whether this characteristics is in line with ...
Kramer, Werner, Hartz, Detlev, Ökonomopulos, Raymond, Pünter, Jürgen, Müller, Günter, Günter Müller, Werner Kramer, Jürgen Pünter, Raymond Ökonomopulos, Detlev Hartz   +9 more
core   +1 more source

Weed Pressure, Nutrient Content, and Seed Yield in Field Grown Sulfonylurea-Resistant Camelina sativa and Brassica napus

, 2022
Camelina [(Camelina sativa (L.) Crantz], an oilseed species of Brassicaceae, does not have approved herbicides for weed control, which limits its expansion as a commercial crop.
Kirk Howatt, Brant B. Bigger, Joseph Mettler, Marisol T. Berti, James V. Anderson   +4 more
core   +1 more source

Bioequivalence Study of a New Generic Fixed-Dose Combination of Sitagliptin (100 mg) and Glimepiride (2 mg) in Healthy Adult Volunteers under Fasting Condition

Chronicle of Diabetes Research and Practice
Introduction: The present study evaluated the bioequivalence of a fixed-dose combination (FDC) of sitagliptin and glimepiride with the originator reference product.
Prashant Kumthekar, Mihir Upadhyay, Koripalli S. Reddy, Sambasiva R. Puram, Basava S. Nallamekala   +4 more
doaj   +1 more source

Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective

İstanbul Medical Journal, 2019
Introduction:We aimed to investigate the levels of receptor activator of nuclear factor kappa-b ligand (RANKL) and osteoprotegerin (OPG) in order to evaluate the negative effects of type 2 diabetes mellitus on bone health and their relationship to the ...
Alper Gümüş, Muhammed Emin Düz, Cihan Coşkun, Mustafa Velet, Macit Koldaş   +4 more
doaj   +1 more source

Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study

Journal of Diabetology, 2020
Introduction: Type 2 diabetes is a major public health problem across all economic regions. This open-label study collected real-world data on patients presenting with type 2 diabetes in Azerbaijan treated with gliclazide modified release (MR). Materials
Valeh A Mirzazada, Ramila A Huseynova, Sevil A Mustafayeva, Fidan N Gasimova, Ulviyya Ahmadova, Narmin Ismayilova, Vafa Kerimova, Hagigat Mehdiyeva, Rana Suleymanova, Zahrakhanim Maharramova, Gulnara Iskandarli, Ofeliya Gurbanova, Sariyya Aghayeva, Sabina Malikova, Konul Ismayilova, Khanim Salimkhanova   +15 more
doaj   +1 more source

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes : a meta-analysis

, 2012
OBJECTIVE: Oral antidiabetic drugs (including metformin and sulfonylurea) may play a role in the relationship between type 2 diabetes and cancer. To quantify the association between metformin and sulfonylurea and the risk of cancer, we performed a meta-
Zambon A, La Vecchia C, C. Bosetti, Corrao G., A. Catapano, Catapano A, Bosetti C, G. Corrao, Grassi G, A. Zambon, D. Soranna, G. Grassi, Mancia G, C. La Vecchia, Soranna D, Scotti L, G. Mancia, L. Scotti, Bosetti, C., La Vecchia, C., Corrao, G., Mancia, G., Catapano, A., Grassi, G., Soranna, D., Scotti, L., Zambon, A.   +26 more
core   +1 more source

Recent Advances in Neonatal Diabetes

Diabetes, Metabolic Syndrome and Obesity, 2020
Amanda Dahl, Seema Kumar Division of Pediatric Endocrinology and Metabolism, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USACorrespondence: Seema KumarDivision of Pediatric Endocrinology and Metabolism, Department of ...
Dahl A, Kumar S
doaj  

Insulin or sulfonylurea treatments of the diabetics differentially affect erythrocyte membrane and serum enzymes and extent of protein glycosylation

, 2001
Erythrocyte membrane protein glycosylation increase by 3.4 fold in diabetes. Insulin or sulfonylurea treatment did not reduce the extent of glycosylation. The serum protein glycosylation was comparable in all the groups including control.
Patel, T. H, Dave, K. R, Katyare, S. S   +2 more
core   +1 more source

Influence of auxin and sulfonylurea herbicides on seeded native communities

, 2004
Sulfonylurea herbicides were used extensively for weed control on Conservation Reserve Program (CRP) seedings, constituting over 98% of the residual herbicides applied from 1986-1990 in southeastern Colorado.
Lair, Kenneth, Redente, Edward F.
core   +1 more source